An 87-year-old man with Alzheimer-type dementia presented to our hospital with pain in the right breast. A physical examination revealed nipple discharge and gynecomastia of the right breast (Picture 1, 2, arrows). He underwent treatment (1 mg risperidone) for 8 months for night delirium. His prolactin levels were increased [68.5 (normal: 3.6-12.8) ng/mL]; however, thyroid function test results were normal. Computed tomography revealed an enlarged right mammary gland. Pituitary magnetic resonance imaging showed no abnormality. Gynecomastia owing to risperidoneinduced hyperprolactinemia was diagnosed. Therefore, risperidone, which was deemed the most likely to induce hyperprolactinemia (1), was discontinued. His breast pain and gynecomastia disappeared within few days (Picture 3, 4); however, his delirium worsened. Quetiapine 12.5 mg/day was initiated, which resolved his delirium; the pa-Sanzai Hospital, Japan
Intern Med 58: 3609-3610, 2019 DOI: 10.2169/internalmedicine.3224-19 tient's prolactin levels were 15.1 ng/mL at 6 months later. Dopamine (D2) receptor blockage by various drugs (especially antipsychotics, antidepressant, and prokinetics) causes increased prolactin secretion (1) . Some atypical antipsychotics (clozapine, aripirazole, olanzapine, and quetiapine) do not increase prolactin secretion because of a low tendency to blockade dopamine receptors as well as a prolactin-sparing effect (1, 2) .
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